Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01758523 · ClinicalTrials.gov registry record · Phase 4
Dutasteride Treatment for the Reduction of Heavy Drinking in Men
A Phase 4 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 189
- Enrollment target
NCT01758523: Completed Phase 4 study, sponsored by UConn Health.
NCT01758523 is a Phase 4 study that has completed, run by UConn Health. The registered enrollment target is 189 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01758523, a Phase 4 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 189 participants
- Enrollment target
Study Summary
This study will examine the safety and potential benefit of the medication dutasteride to help men reduce or stop drinking alcohol.
Primary Outcome
Number of days / study week with 5 or more drinks consumed
Interventions
- DRUG Dutasteride
- DRUG sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-02-28 |
| Phase | Phase 4 |
What the finished NCT01758523 record still lists
NCT01758523 is an interventional study that assigns participants to a tested intervention. The registered 189 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 2 interventions - of which Dutasteride is the first listed.
NCT01758523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01758523 about?
NCT01758523 is a clinical study titled "Dutasteride Treatment for the Reduction of Heavy Drinking in Men". This study will examine the safety and potential benefit of the medication dutasteride to help men reduce or stop drinking alcohol.
What is the current status of trial NCT01758523?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 189 participants. The study started on 2013-01. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT01758523?
The interventions under investigation include: Dutasteride (DRUG), sugar pill (DRUG).
Who is sponsoring clinical trial NCT01758523?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01758523's enrollment target sits among peer trials
189 456th of 2000 higher than 1,545 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02734537 · 189 participants · Phase 2
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- NCT05058651 · 189 participants · Phase 2
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- NCT05673408 · 189 participants
NIBP Validation Study
- NCT05994209 · 189 participants · Phase 1
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia